Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had revenue of $715.00K in the quarter ending March 31, 2024. This brings the company's revenue in the last twelve months to $1.90M. In the year 2023, Iovance Biotherapeutics had annual revenue of $1.19M.

• Revenue (ttm): $1.90M
• Revenue Growth: n/a
• P/S Ratio: 1,359.48
• Revenue / Employee: $3,418
• Employees: 557
• Market Cap: 2.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.